Impact of a keto diet on symptoms of Parkinson's disease, biomarkers, depression, anxiety and quality of life: a longitudinal study.
Melanie M TidmanDawn Reid WhiteTim A WhitePublished in: Neurodegenerative disease management (2024)
Aim: Evidence suggests low-carbohydrate diets (LCHF) may assist in treating neurodegenerative diseases such as Parkinson's disease (PD); however, gaps exist in the literature. Patients & methods: We conducted a small 24-week pilot study to investigate the effects of an LCHF diet on motor and nonmotor symptoms, health biomarkers, anxiety, and depression in seven people with PD. We also captured patient experiences during the process (quality of life [QoL]). Results: Participants reported improved biomarkers, enhanced cognition, mood, motor and nonmotor symptoms, and reduced pain and anxiety. Participants felt improvements enhanced their QoL. Conclusion: We conclude that an LCHF intervention is safe, feasible, and potentially effective in mitigating the symptoms of this disorder. However, more extensive randomized controlled studies are needed to create generalizable recommendations.
Keyphrases
- sleep quality
- physical activity
- end stage renal disease
- weight loss
- parkinson disease
- depressive symptoms
- randomized controlled trial
- healthcare
- mental health
- systematic review
- newly diagnosed
- chronic kidney disease
- chronic pain
- double blind
- pain management
- case report
- bipolar disorder
- placebo controlled
- peritoneal dialysis
- phase iii
- open label
- risk assessment
- multiple sclerosis
- climate change
- spinal cord injury
- deep brain stimulation
- phase ii
- study protocol